Nature Communications (Jan 2021)

HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)

  • Natalie N. Kinloch,
  • Yanqin Ren,
  • Winiffer D. Conce Alberto,
  • Winnie Dong,
  • Pragya Khadka,
  • Szu Han Huang,
  • Talia M. Mota,
  • Andrew Wilson,
  • Aniqa Shahid,
  • Don Kirkby,
  • Marianne Harris,
  • Colin Kovacs,
  • Erika Benko,
  • Mario A. Ostrowski,
  • Perla M. Del Rio Estrada,
  • Avery Wimpelberg,
  • Christopher Cannon,
  • W. David Hardy,
  • Lynsay MacLaren,
  • Harris Goldstein,
  • Chanson J. Brumme,
  • Guinevere Q. Lee,
  • Rebecca M. Lynch,
  • Zabrina L. Brumme,
  • R. Brad Jones

DOI
https://doi.org/10.1038/s41467-020-20442-3
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 10

Abstract

Read online

The intact proviral DNA assay quantifies the genomically intact HIV reservoir, but assay failure due to HIV-1 polymorphism has been observed. Here, the authors report a 28% failure rate in a cohort of people with HIV-1, and note within-host HIV-1 diversity as a further challenge to IPDA accuracy.